Next Article in Journal
Aneuploid CTC and CEC
Next Article in Special Issue
Whole-Body MRI with Diffusion-Weighted Imaging in Bone Metastases: A Narrative Review
Previous Article in Journal
Optimization of Stress-Based Microfluidic Testing for Methicillin Resistance in Staphylococcus aureus Strains
Previous Article in Special Issue
Dosimetry-Based Consideration on Remission and Relapse after Therapy with 223Ra-Dichloride in Castration-Resistant Prostate Cancer (CRPC) with Bone Metastases. A Case Report
Article Menu
Issue 2 (June) cover image

Export Article

Open AccessReview
Diagnostics 2018, 8(2), 25; https://doi.org/10.3390/diagnostics8020025

Percutaneous, Imaging-Guided Biopsy of Bone Metastases

2nd Radiology Department, University General Hospital “ATTIKON”, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece
*
Author to whom correspondence should be addressed.
Received: 20 January 2018 / Revised: 10 April 2018 / Accepted: 16 April 2018 / Published: 18 April 2018
(This article belongs to the Special Issue Imaging of Bone Metastases in Oncology)
Full-Text   |   PDF [916 KB, uploaded 3 May 2018]   |  

Abstract

Approximately 70% of cancer patients will eventually develop bone metastases. Spine, due to the abundance of red marrow in the vertebral bodies and the communication of deep thoracic-pelvic veins with valve-less vertebral venous plexuses, is the most common site of osseous metastatic disease. Open biopsies run the risk of destabilizing an already diseased spinal or peripheral skeleton segment. Percutaneous biopsies obviate such issues and provide immediate confirmation of correct needle location in the area of interest. Indications for percutaneous bone biopsy include lesion characterization, optimal treatment and tumor recurrence identification, as well as tumor response and recurrence rate prediction. Predicting recurrence in curative cases could help in treatment stratification, identification, and validation of new targets. The overall accuracy of percutaneous biopsy is 90–95%; higher positive recovery rates govern biopsy of osteolytic lesions. The rate of complications for percutaneous biopsy approaches is <5%. The purpose of this review is to provide information about performing bone biopsy and what to expect from it as well as choosing the appropriate imaging guidance. Additionally, factors governing the appropriate needle trajectory that would likely give the greatest diagnostic yield and choice of the most appropriate biopsy system and type of anesthesia will be addressed. View Full-Text
Keywords: bone; metastasis; percutaneous; biopsy; imaging-guided bone; metastasis; percutaneous; biopsy; imaging-guided
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Filippiadis, D.; Mazioti, A.; Kelekis, A. Percutaneous, Imaging-Guided Biopsy of Bone Metastases. Diagnostics 2018, 8, 25.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Diagnostics EISSN 2075-4418 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top